PaxMedica Competitors and Similar CompaniesClear all
PaxMedica's competitors and similar companies include GW Pharmaceuticals, Yamo Pharmaceuticals, Curemark and Elpiscience Biopharmaceuticals.
 PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  GW Pharmaceuticals GW Pharmaceuticals is a biopharmaceutical company that develops and markets cannabinoid prescription medicines using botanical extracts. |  Yamo Pharmaceuticals Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. |  Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  Elpiscience Biopharmaceuticals Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy. | |
Founding Date | Founding Date 2018 | Founding Date 1998 | Founding Date N/A | Founding Date 2006 | Founding Date 2017 |
Type | Type Public | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Tarrytown, US HQ | Locations Cambridge, GB HQ | Locations HQ | Locations Rye, US HQ Rye Brook, US | Locations CN HQ Suzhou Shi, CN |
Employees | Employees 2100% increase | Employees 2302% decrease | Employees 6 | Employees 23 | Employees 33 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 5.4m (over 6 years ago) | Latest funding round $ 100m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 55.7m | Total funding raised $ 155m |
For sources of this data, please see the company profile
View Company Profiles
GW Pharmaceuticals
HQ
Cambridge, GB
GW Pharmaceuticals is a biopharmaceutical company that develops and markets cannabinoid prescription medicines using botanical extracts.
View companyYamo Pharmaceuticals
HQ
Employees
6
Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism.
View companyCuremark
HQ
Rye, US
Employees
23
Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders.
View companyElpiscience Biopharmaceuticals
HQ
CN
Employees
33
Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy.
View company